Attended by executive thought leaders and innovative companies, the 2019 DxConference feature a lineup of experts from payers, leading diagnostics companies and firms working to advance the industry. 


Payer Panels

In parallel to the main conference, exclusive panels with payer medical directors, are open on a first-come basis to companies seeking an unmatched opportunity to learn about reimbursement direct from the source. 


DxCONFERENCE IS THE PREMIER VENUE FOR THOUGHT LEADERS AND EXECUTIVES in personalized medicine seeking to successfully launch and grow new diagnostics. Hosted by AccessDx, participants bring perspectives from leading diagnostic companies, pharmaceutical manufacturers, payers, and other stakeholders. 

The Spring 2019 edition will explore the rise of companion diagnostics and how pharma and diagnostics companies can collaborate to increase opportunities in a growing market.

Attendees will build their networks with decision makers in interactive professional and social settings, and come away better equipped to address opportunities and challenges in the diagnostics marketplace.    



Who Should Attend?

DxConference is ideal for executives from diagnostics and pharmaceutical manufacturers, as well as Medical Directors, Reimbursement Directors, Case Managers, Sales and Marketing Directors, and leaders from other healthcare organizations with a strategic investment in diagnostics.





The fall event will be held October 2019 in San Francisco, California at the Hyatt Regency San Francisco Airport


The 2019 spring event is TBD in Boston, Massachusetts at the Seaport Hotel & World Trade CenterOne



Registration Rate:

$1,595 - Early Bird: By 10/04/2019

$1,895 - Standard Rate: After 10/05/2019

Please contact us for Group Discounts.

ACCOMMODATIONS: A block of hotel rooms and reservations for DxConference will be available when you register online.


Keynote Speakers

The 2019 DxConference in Boston features a lineup of experts from payers, leading diagnostics companies and firms. Speakers will be announced in the full Agenda shortly. 


Brian Carey

Partner, Foley Hoag

Brian Carey’s legal practice focuses on advising a wide range of clients on federal legislative and regulatory issues impacting the life sciences and health care sectors. He primarily advises biotechnology, medical device companies, health care providers, medical trade associations and private equity investors.

His work with biopharma and medical technology companies includes advice on Medicare coverage and payment, and food and drug approval issues for innovative technologies. He regularly represents clients in matters before the Congress, Department of Health and Human Services, and federal agencies.

In recent years, Brian has been counseling clients on the implementation of the Affordable Care Act.


Delivering on the Promise of Personalized Medicine®

We believe that personalized medicine is talked about a lot but not done enough. We have gathered industry leaders to assist you (diagnostic innovators and manufacturers) in successfully launching personalized medicine diagnostics (PMDx) in the United States.

Learn more at AccessDx.



Corporate Sponsors


Healthcare is one of the most intricate and constantly changing areas of the law. For nearly seven decades, Foley Hoag has kept its healthcare clients ahead of the shifts and out of the gray areas with an approach built on its deep understanding of healthcare law and a strong tradition of developing innovative legal solutions to your needs.


At 21st Century Medicine, our mission is to improve the quality of healthcare by encouraging research, development, and commercialization of innovative diagnostic technologies that personalize patient care, improve patient outcomes, and substantially reduce healthcare costs.